Genentech Rx For Global Pricing: Refuse To Sell Unless Price Is “Reasonable”
Executive Summary
Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference
You may also be interested in...
Rx Industry Should Support Imports To Block Other Price Controls – Attorney
Drug manufacturers should support a legalized drug importation system because it is the most benign form of cost containment facing the industry, Mayer, Brown, Rowe & Maw Partner Alvin Lorman said
Rx Industry Should Support Imports To Block Other Price Controls – Attorney
Drug manufacturers should support a legalized drug importation system because it is the most benign form of cost containment facing the industry, Mayer, Brown, Rowe & Maw Partner Alvin Lorman said
Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS
FDA is likely entering another extended period with Deputy Commissioner Lester Crawford, PhD, at the helm following Commissioner McClellan's move to the Centers for Medicare & Medicaid Services